Voyager Therapeutics, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Voyager Therapeutics is a Lexington, Massachusetts–based biotechnology company focused on applying human genetics to influence the progression of neurological diseases, with an eye toward potential cures. Its pipeline covers Alzheimer’s disease, Friedreich’s ataxia, Parkinson’s disease, and ALS, among other central nervous system disorders, with many programs deriving from its TRACER AAV capsid discovery platform, which supports brain delivery of genetic medicines after intravenous dosing. Some programs are wholly owned, while others advance in collaborations with partners including Alexion, AstraZeneca Rare Disease, Novartis, and Neurocrine Biosciences.